首页>
外国专利>
NOVEL ENTEROCOCCUS FAECIUM BACTERIOPHAGE ENT-FAP-4 AND USE FOR INHIBITING ENTEROCOCCUS FAECIUM PROLIFERATION OF SAME
NOVEL ENTEROCOCCUS FAECIUM BACTERIOPHAGE ENT-FAP-4 AND USE FOR INHIBITING ENTEROCOCCUS FAECIUM PROLIFERATION OF SAME
展开▼
机译:新型肠球菌粪便噬菌体ENT-FAP-4及其用于抑制相同肠球菌粪便繁殖的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a Siphoviridae bacteriophage Ent-FAP-4 (Accession number: KCTC 12854BP) isolated from nature, which has the ability to specifically kill Enterococcus faecium and has the genome represented by SEQ ID NO: 1, a pharmaceutical composition containing the Siphoviridae bacteriophage Ent-FAP-4 as an active ingredient, and a method of preventing or treating a disease caused by Enterococcus faecium using the pharmaceutical composition.
展开▼
机译:本发明涉及一种从自然界分离的幽门螺杆菌 I>噬菌体Ent-FAP-4(保藏号:KCTC 12854BP),其具有特异性杀死粪肠球菌 I>的能力,并具有SEQ ID NO:1表示的基因组,包含病毒科 i>噬菌体Ent-FAP-4作为有效成分的药物组合物,以及预防或治疗由粪肠球菌引起的疾病的方法使用药物组合物。
展开▼